Cover - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2025 |
Jun. 08, 2026 |
|
| Cover [Abstract] | ||
| Document Type | 10-Q/A | |
| Amendment Flag | true | |
| Amendment Description | This Amendment No. 1 on Form 10-Q/A (the “Amendment”) to the Quarterly Report on Form 10-Q of FDCTech, Inc. (the “Company”) for the three and six months ended June 30, 2025 (the “Original Filing”), as filed with the Securities and Exchange Commission (“SEC”) on August 14, 2025, is being filed to restate the Company’s previously issued condensed consolidated financial statements for the three and six months ended June 30, 2025, and the comparative period.As previously disclosed in a Current Report on Form 8-K filed by the Company on June 8, 2026, the Board of Directors of the Company, after consultation with management and the Company’s independent registered public accounting firm, concluded that the Company’s previously issued unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2025 should no longer be relied upon because of errors in those financial statements. The Company is filing this Amendment to restate the affected financial statements in accordance with Accounting Standards Codification (“ASC”) Topic 250, “Accounting Changes and Error Corrections.” This Amendment amends and restates Items 1, 2, and 4 of Part I of the Original Filing. The restatement adjustments are described in detail in Note 2 (Restatement of Previously Issued Financial Statements) to the unaudited condensed consolidated financial statements included in this Amendment. The principal restatement items relate to: (i) reclassification of a subscription receivable from current assets to a contra-equity account; (ii) recognition of 500,000 shares of common stock issued in October 2021 that were not previously recorded in the Company’s share register; (iii) separate presentation of restricted cash representing client funds segregated under regulatory requirements; (iv) correction of the noncontrolling interest walk in accordance with ASC 810-10; (v) correction of the allocation of accumulated other comprehensive income in accordance with ASC 220-10; (vi) corrections to the results of operations, principally within other income (expense), which reduced the net loss for the six months ended June 30, 2025 by $207,915; (vii) the reclassification of cost of sales between the Technology & software and Brokerage segments; and (viii) the reclassification from “Cash” of $7,074,201 of client funds of Alchemy Prime Limited and external third-party assets held by Alchemy Markets Ltd. to “Restricted cash — client funds (segregated)” with corresponding recognition in “Client funds payable.” In addition, this Amendment expands the disclosure of legal proceedings in (i) the notes to the unaudited condensed consolidated financial statements, (ii) Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and (iii) Part II, Item 1, Legal Proceedings, to describe matters that existed as of June 30, 2025 and developments thereafter through the date of this Amendment, which were not disclosed in the Original Filing. These expanded legal proceedings disclosures supplement, but do not modify, the financial statements being restated. Concurrently with this Amendment, the Company has filed Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, Amendment No. 2 to its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, and Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, each reflecting consistent restatement adjustments and legal proceedings disclosures. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Amendment includes currently-dated certifications from the Company’s Chief Executive Officer and Chief Financial Officer as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, filed as exhibits hereto. Except as expressly set forth in this Amendment, this Amendment does not, and does not purport to, amend, update, or restate any other information or disclosures contained in the Original Filing, or reflect any events occurring after the date of the Original Filing. Accordingly, this Amendment should be read in conjunction with the Company’s filings with the SEC subsequent to the Original Filing. | |
| Document Quarterly Report | true | |
| Document Transition Report | false | |
| Document Period End Date | Jun. 30, 2025 | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2025 | |
| Current Fiscal Year End Date | --12-31 | |
| Entity File Number | 000-56338 | |
| Entity Registrant Name | FDCTECH, INC. | |
| Entity Central Index Key | 0001722731 | |
| Entity Tax Identification Number | 81-1265459 | |
| Entity Incorporation, State or Country Code | DE | |
| Entity Address, Address Line One | 200 Spectrum Center Drive | |
| Entity Address, Address Line Two | Suite 300 | |
| Entity Address, City or Town | Irvine | |
| Entity Address, State or Province | CA | |
| Entity Address, Postal Zip Code | 92618 | |
| City Area Code | (877) | |
| Local Phone Number | 445-6047 | |
| Title of 12(b) Security | Common Stock, par value $0.0001 | |
| Trading Symbol | FDCT | |
| Entity Current Reporting Status | Yes | |
| Entity Interactive Data Current | Yes | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business | true | |
| Entity Emerging Growth Company | true | |
| Elected Not To Use the Extended Transition Period | false | |
| Entity Shell Company | false | |
| Entity Common Stock, Shares Outstanding | 423,084,729 | |
| Entity Listing, Par Value Per Share | $ 0.0001 |